Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor

British Journal of Pharmacology

Volumn 128, Issue 5, 1999, Pages 999-1010

  Huang, Y T ^a   Hwang, J J ^b   Lee, P P ^c   Ke, F C ^d   Huang, J H ^a   Huang, C J ^a   Kandaswami, C ^e   Middleton, Jr ^e   Lee, M T ^a  

^a INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NONE

Author keywords

Epidermal growth factor receptor; Luteolin; Matrix metalloproteinase; Metastasis; Protein tyrosine kinase; Quercetin

Indexed keywords

CELL DNA; DNA FRAGMENT; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FLAVONOID; GELATINASE A; GELATINASE B; LUTEOLIN; PROTEIN TYROSINE KINASE INHIBITOR; QUERCETIN;

ARTICLE; AUTOPHOSPHORYLATION; CELL GROWTH; CELL PROLIFERATION; CELL SHAPE; CHEMICAL BOND; GROWTH INHIBITION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR CELL LINE;

AUTORADIOGRAPHY; BLOTTING, WESTERN; CELL DIVISION; DENSITOMETRY; DNA FRAGMENTATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; LUTEOLIN; MATRIX METALLOPROTEINASES; NEOPLASM METASTASIS; PHOSPHORYLATION; PHOSPHOTYROSINE; PRECIPITIN TESTS; PROTEIN-TYROSINE KINASES; QUERCETIN; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0032756794     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702879     Document Type: Article

References (63)

1. AGULLO, G., GAMET-PAYRASTRE, L., MANENTI, S., VIALA, C., REMESY, C., CHAP, H. & PAYRASTRE, B. (1997). Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison wilh tyrosine kinase and protein kinase C. Biochem. Pharmacol., 53, 1649-1657.
2. AKIYAMA, T., ISHIDA, J., NAKAGAWA, S., OGAWARA, H., WATANABE, S., ITOH, N., SHIBUYA, M. & FUKAMI, Y. (1987). Genistein, 4 specific inhibitor of tyrosine kinases. J. Biol. Chem., 262, 5592-5595.
3. ARMSTRONG, D.K., ISACCS, J.T., OTTAVINO, Y.L. & DARIDSON, N.E. (1992). Programmed cell death in an estrogen-independent human cancer cell line, MDA-MB-468. Cancer Res., 52, 3418 -3424.
4. BISHOP, J.M. (1987). The molecular genetics of cancer. Science, 235, 305-311.
5. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the protein-dye binding. Anal. Biochem., 72, 248-254.
6. CANTLEY, L.C., AUGER, K.R., CARPENTER, C., DUCKWORTH, B., GRAZIANI, A., KAPELLER, R. & SOLTOFF, S. (1991). Oncogenes and signal transduction. Cell, 64, 281-302.
7. CHA, I.-J., BAE, S.-K., LEE, H.-Y., LEE, O.-H., SATO, H., SEIKI, M., PARK, B.-C. & KIM, K.-W. (1996). Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT-1089 human fibrosacoma cells. Cancer Res., 56, 2281-2284.
8. COHEN, S., USHIRO, H., STOSCHECK, C. & CHINKERS, M. (1982). A native 170,000 epidermal growth factor receptor kinase complex from shed membrane vesicles. J. Biol. Chem., 257, 1523-1531.
9. CONSTANTINOU, A., KIGUCHI, K. & HUBERMAN, E. (1990). Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res., 50, 2618-2624.
10. DAVIES, B.D., WAXMAN, J., WASAN, H., ABEL, P., WILLIAMS, G., KRAUSZ, T., NEZI, D., THOMAS, D. & BALKWILL, T.R. (1993). Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion. Cancer Res., 53, 5365-5369.
11. DAVIS, B.D., BROWN, P.D., EAST, N., CRIMMIN, M.J. & BALKWILL, F.R. (1993). A synthetic matrix metalloproteinase inhibitor decrease tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res., 53, 2087-2091.
12. KOTSIS, T., PEPPER, M.S., AKTAS, E., BREIT, S., RASKU, S., ADLEFRCREUTZ, H., WAHALA, K., MONTESANO, R. & SCHWEIGERER, L. (1997). Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res., 57, 2916-2921.
13. FRANK, D.A. & SARTORELLI, A.C. (1988). Biochemical characterization of tyrosine kinase and phosphotyrosine phosphatase activities of HI.-60 leukemia cells. Cancer Res., 48, 4299-4306.
14. GLOSSMAN, H.P., PRESEK, P. & FIGENBRODT, E. (1981). Quercetin inhibits tyrosine phosphorylation by the cyclic nucleotide-independent transforming protein kinase, pp 60. Naunyn-Schmiedeberg's. Arch. Pharmacol., 217, 100-102.
15. GRAZIANI, Y., ERIKSON, E. & ERIKSON, R.L. (1983). The effect of the phosphorylation activity of the ras sarcoma virus transforming gene product in vitro and in vivo. Kur. J. Biochem., 135, 583-589.
16. HAMDY, F.C., FADLON, E.J., COTTAM, D., LOWRY, J., THURREL, W., SILOCKS, P.B., ANDERSON, J.B., WILLIAMS, J.L. & REES, R.C. (1994). Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Br. J. Cancer., 69, 177-182.
17. HERRON, G.S., BANDA, M.J., CLARK, R.J., GAVRILOVIC, J. & WERB, Z. (1986). Secretion of metalloproteinases bystimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J. Biol. Chem., 261, 2814-2818.
18. HEUSSEN, C. & DOWDLE, E.B. (1980). Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrate. Anal. Biochem., 102, 196-202.
19. HIBBS, M.S., HASTY, K.A., SEVER, J.M., KANG. A.H. & MAINARDI, C.L. (1985). Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J. Biol. Chem., 260, 2493-2500.
20. HUNTER, T. & COOPER, J.A. (1985). Protein tyrosinc kinase. Annul. Rev. Biochem., 54, 897-930.
21. KANDIMSWAMI, C., PERKINS, F., DRZEWIECKI, G., SOLONIUK, D.S. & MIDDLETON. (1992). Differential inhibition of proliferation of human squamous cell carcinoma, gliosarcoma and embryonic fibroblast-like lung cells in culture by plant flavonoids. Anti-Cancer Drugs., 3, 525-530.
22. KANDASWAMI, C., PERKINS, E., SOLOMUK, D.S., DRZEWIECKI, G. & MIDDLETON, F. (1991). Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. Cancer Lett., 56, 147-152.
23. KERR, L.D., HOLT, J.T. & MATRISIAN, L.M. (1988). Growth factors regulate transin gene expression by c-fos and c-fos independent pathways. Science, 242, 1424-1427.
24. KERR, L.D., MILLER, D.B. & MATRISIAN, L.M. (1990). TGP-β inhibition of transin/stromelysin gene expression is mediated through a c-fos binding sequence. Cell., 61, 267-278.
25. KOCH, C.A., ANDERSON, D., MORAN, M.F., ELLI, T. & PAWSON, T. (1991), SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science, 252, 668-674.
26. KOLIBABA, K.S. & DRUKER, B.J. (1997). Protein tyrosine kinases and cancer. Biochim Biophys Acta., 1333, F217-F248.
27. KUHNAU, J. (1976). The flavonoids: a class of semi-essential food components: their role in human nutrition. World Rev. Nutr. Diet., 24, 117-191.
28. LAEMMLI, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
29. LEE, M.T., LEE, P.P., KE, F.C., LO, T.B., LEE, M.S., HUANG. Y.T., LIEBOW, C., SCHALLY, A.V. & HWANG, J.J. (1997). Opposite effect of EGF and analog of LHRH and somatostatin on matrix metalloproteinases expression and cell growth of tumor cells. Proc. Am. Associ. Cancer. Res., 38, 405.
30. LEE, M.T., LIEBOW. C., KAMER, A. & SCHALLY. A.V. (1991). Effect of epidermal growth factor and analogue of luteinizing hormone releasing hormone and somatoslatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors. Proc. Natl. Acad. Sci. USA., 88, 1656-1660.
31. LIABAKK, N.B., TALBOT, I., SMITH, R.A., WILKINSON, K. & BALKWILL, F. (1996). Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res., 56, 190-196.
32. LIEBOW C., CREAN, D.H., LEE, M.T., KAMER, A.R., MANG, T.S. & SCHALLY. A.V. (1994). Synergistic effects of bombesin and epidermal growth factor. Proc. Natl. Acad. Sci. U.S.A., 91, 3804-3808.
33. LIEBOW, C., REILLY, C., SERRNO, M. & SCHALLY, A.V. (1989). Somatostatin analogue inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc. Natl. Acad. Sci. U.S.A., 86, 2003-2007.
34. LINASSIER, C., PIERRE, M., I.F. PECO, J.-B, & PIERRE, J. (1990). Mechanism of action in NIH-.VH cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem. Pharmacol., 39, 187-193.
35. LIOTTA, L.A. (1992), Cancer cell invasion and metastasis. Sci. Am. Feb., 266, 54-59, 62-63.
36. LIOTTA, L.A., STEEG, P.S. & STETLER-STEVENSON. (1990. Cancer metastasis and angiogcnesis: an imbalance of positive and negative regulation. Cell. 64, 327-336.
37. LEVI, J., TEUERSTEIN, I., MARBACH, M., RADIANS, S. & SHARONI, Y. (1984). Tyrosine protein kinase activity in the DMBA-induced rat mammary tumor: inhibition by quercetin. Biochem. Biophys. Res. Commun., 123, 1227-1233.
38. MATRISIAN, L.M. (1990). Metalloproteinases and their inhibitors in matrix remolding. Trends Genet., 6, 121-125.
39. MATRISIAN, L.M. (1992). The matrix-degrading metalloproteinases. BioEssays., 14, 455-462.
40. MCDONNEL, S.E. & FINGLETON, B. (1993). Role of matrix metalloproleinasc in invasion and metastasis: biology, diagnosis and inhibitors. Cytutechnologv, 12, 367-384.
41. MCDONNEL, S.E., KERR, L.D. & MATRISIAN, L.M. (1990). Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of prolo-oncogenc c-fos and c-jun and activation of protein kinase C. Mol. Cell. Biol., 10, 4284-4293.
42. MENON, L.G., KUTTAN, R. & KUTTAN, G. (1995). Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett, 95, 221-225.
43. MERLINO, G.T., XU, Y.H. ISHII, S., CLARK, A.J., SEMBA, K., YAMAMOTO, T. & PASTAN, I. (1984). Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. Science, 224, 417-419.
44. MIDDLETON, E. & KANDASWAMI, C. (1993). In 'The Flavonoids: Advances in Research'. J.B. Harborne, (ed). Chapman and Hall: London, pp. 619-649.
45. MOSMANN, T.J. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity. J. Immunol. Methods., 65, 55-63.
46. NAYLOR, M.S., STAMP, G.W., DAVIES, B.D. & BALKWILL, F.R. (1994). Expression and activity of MMPs and their regulators in ovarian cancer. Intl. J. Cancer., 5K, 50-56.
47. OTANI, H., ERDOS, M. & LEONARD, W.J. (1993). Tyrosine kinase(s) regulate apoptosis and bcl-2 expression in a growth factor-dependent cell line. J. Biol. Chem., 268, 22733-22736.
48. PETERSON, G. & BARNES, S. (1993). Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate., 22, 335-345.
49. PIERCE, J.H., RUGGIERO, M., FLEMING, T.P., DIFIOURE, P.P., GREENBERGER, J.S., VARTIOCOVSKI, L., SCHLESSINGER, J., ROVERA, G. & AARONSON, S.A. (1988). Signal transduction through the EGP receptor transafected in IL-3-dependent hematopoietic cells. Science, 239, 628-631.
50. RICE-EVANS, C.A., MILLER, N.J. & PAGANGA, G. (1996). Structure-antioxidant activity relationships of flavonoids and phenolic acid, Free Radic. Biol. Med., 20, 933-956.
51. SAMUELS, M.L., WEBER, M.L., BISHOP, J.M. & MCMAHON, M. (1993). Conditional transformation of cells and rapid activation of the milogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol. Cell. Biol., 13, 6241-6252.
52. SAVILL, J., FADOK, V., HENSON, P. & HASLETT, C. (1993). Phagocyte recognition of cells undergoing apoptosis. Inmunol. Today., 14, 131-136.
53. SCAMBIA, G., RANELLETTI, F.O., BENEDETTI PANICI, P., PIANTELLI, M., BONANNO, G., DE VINCENZO, R., FERRANDINA, G., RUMI, C., LAROCCA, L.M. & MANCUSO, S. (1990). Inhibitory effect of quercelin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells. Br. J. Cancer., 62, 942-946.
54. SCHNEIDER, M.R. & SCHIRNER, M. (1993). Antimetastatic prostacyclin analogs. Drugs Future 18(1), 29 -48.
55. SCHOLAR, E.M. & TOEWS, M.L. (1994). Inhibition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genistein. Cancer Lett., 9, 87, 159-162.
56. SOULINNA, E.M., BUCHSBAUM, R.N. & RACKER, E. (1975). The effect of flavonoids on aerobic glycolysis and growth of tumor cells. Cancer Res., 35, 1865-1872.
57. TANIGUCHI, S., FUJIKI, H., KOBAYASHI, H., GO, H., MIYADO, K., SADANO, H. & SHIMOKAWA, R. (1992). Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett., 65, 51-54.
58. TOWBIN, H., STAEHELIN. T. & GORDON. J. (1979). Electrophoretic transfer of proteins from poly-acrylamide gels to nitrocellur sheets: procedure and some application. Proc. Natl. Acad, Sci. U.S.A., 76, 4350-4354.
59. ULLRlCH, A. & SCHLESSINGER, J. (1990). Signal transduclion by receptors with tyrosine kinase activity. Cell, 61, 203-212.
60. WATSON, S.A., MORRIS, T.M., ROBINSON, G., CRIMMIN, M.J., BROWN. P.D. & HARDCASTLE, J.D. (1995). Inhibition of organ invasion by the metalloproteinase inhibitor Batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res., 55, 3629-3633.
61. YONEDA, J., KUNIYASU, H., CRISPENS, M.A., PRICE, J.E., BUCANA, C.D. & FIDLER, L.J. (1998). Expression of angiogenesis-related genes and progression of Human Ovarian carcinomas in nude mice. J. Natl Cancer. Inst., 90, 6, 447-454,
62. YOUSEFI, S.. GREEN, D.R., BLASER, K. & SIMON, H.-U. (1994). Protein tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc. Natl. Acad. Sci. U.S.A., 91, 10868-10872.
63. ZHANG, L., LAU, Y.-K., XI, L., HONG, R.-L., KIM, D.S.H.L., CHEN, C.-F., HORTOBAGYI, C.C.-J. & HUMG, M.-C. (1998). Tyrosine kinase inhibitors, emodin and its derivate repress Her-2/neu-induced cellular transformation and metastasis-associatedproperties. Oncogene, 16, 2855-2863.